VC funding update: Boston-area startups that raised money in February
2021 Massachusetts IPOs
5 DCF clients make the 2021 list of top 10 Venture Capital Deals in Massachusetts Biotech
Fierce Biotech has named their 2021 “Fierce 15”, which designates the most promising early-stage biotechnology companies in the industry.
Biotechnology Company, Monte Rosa Therapeutics, Inc., announced the pricing of its initial public offering of 11,700,000 shares of common stock .
VC funding update: Boston startups and tech firms raised $3.5B in January
Top 10 Massachusetts VC Deals of 2020
Tessera Therapeutics announced that it has raised over $230M in Series B financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine.
Cullinan Management announced the pricing of its upsized initial public offering of 11,900,000 shares of common stock.